Medication reminders
with automatic doctor reports.

The gap between what patients say they took and what they actually took

Every physician has experienced this. A patient comes in with blood pressure that is still not controlled despite being on three antihypertensives. The doctor asks: "Are you taking your medications every day?" The patient says yes. The dose gets increased. Six weeks later, the blood pressure is still not controlled. The dose gets increased again. Eventually, the patient ends up on a high dose of three medications for a condition that might have been controlled on lower doses. If anyone had known the real adherence picture.

This is not a failure of honesty in most cases. Patients are not lying to their doctors. They genuinely believe they are taking their medications more consistently than they are. When someone takes seven medications and occasionally forgets the afternoon dose, they remember the doses they took far more clearly than the doses they did not. The result is a sincere but systematically inaccurate self-report.

A review by the NIH Adherence Network (Stirratt et al., Translational Behavioral Medicine, 2015) found that self-reports tend to overestimate adherence compared with other ways of measuring it. For medications where the therapeutic effect is dose-dependent and cumulative (statins, antihypertensives, antidepressants, immunosuppressants) that gap can be clinically significant.

The downstream consequences of inaccurate adherence data

When a physician believes a patient is adherent and the treatment is still not working, the next step is escalation: higher doses, additional medications, or the conclusion that the current drug class is ineffective and a switch is needed. All of these interventions carry their own risks and costs. Higher doses of antihypertensives can cause hypotension and falls in elderly patients. Adding a fourth medication to someone already on three increases the complexity of the regimen, and often decreases adherence further. Switching drug classes when the first class would have worked requires an adjustment period and may expose the patient to a new side effect profile.

The IMS Institute for Healthcare Informatics, 2012 estimated that suboptimal use of medicines, including poor adherence, causes about $500 billion in avoidable costs worldwide each year. Part of that gap starts with clinicians working from inaccurate information about whether their patients are actually taking the treatments they have prescribed.

• The adherence reporting gap: Patients tend to overestimate their medication adherence when recalling from memory. This distorts every clinical decision that depends on knowing whether the current treatment is working.
• Escalation based on false non-response: When a physician believes a patient is adherent and the drug is not working, the logical next step is dose escalation or medication change. When the real problem is inconsistent adherence, these escalations are unnecessary and potentially harmful.
• No reporting tool in standard apps: Many medication reminder apps keep a medication history log. Cureva adds a formatted, shareable report designed for clinical use, generated automatically each week.
• The memory limitation: No patient can reliably recall which specific days they missed which medications over a 4-week period. Asking them to do so at a physician appointment is a task that exceeds human memory capacity, even for highly motivated patients.

How the reporting feature changes clinical decision-making

Medication adjustment based on real patterns

A patient is consistently missing their 3pm dose of a twice-daily medication. They take the morning dose reliably but miss the afternoon one because they are at work and the reminder goes unnoticed. Their average adherence is 65%. The physician, who previously believed adherence was near-perfect, now has the actual data. Instead of increasing the morning dose (which risks over-medication), they can explore a once-daily formulation or reposition the reminder timing. One data point (the consistent pattern of afternoon misses) transforms a baffling treatment failure into an obvious scheduling problem with a straightforward solution.

Avoiding unnecessary medication escalation

A patient's HbA1c is still elevated at their quarterly check-in. The physician is considering adding a second diabetes medication. The Cureva weekly report shows that the patient's metformin adherence for the past 90 days has averaged 52%. The physician now knows the appropriate first step is not escalation. It is adherence support. Addressing why the patient is missing half their doses is the clinical priority. The data prevented an unnecessary medication addition and pointed to the real problem.

Validating treatment success

A patient's blood pressure has come under control over the past three months. The physician wants to know whether this is because the medication is working or because the patient changed other lifestyle factors. The Cureva report shows 91% adherence over the period, with blood pressure readings trending downward in clear correlation with adherence, including two brief upticks during weeks when the patient had lower adherence. The data tells a coherent story that supports keeping the current treatment plan rather than making changes.

Supporting medication reviews and polypharmacy management

For elderly patients on multiple medications (five, seven, ten or more) an annual medication review by a pharmacist or physician is a critical safety check. The Cureva report gives the reviewing clinician a complete picture: which medications are being taken consistently, which are being missed regularly, and which are showing adherence patterns that suggest the patient finds them difficult to manage. This information is typically unavailable in any other format, because no other source tracks actual adherence with timestamps across an entire medication regimen.